Natixis Advisors, L.P. Glaukos Corp Transaction History

Natixis Advisors, L.P.

$63 Billion
Q2 2025

A detailed history of Natixis Advisors, L.P. transactions in Glaukos Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 26,972 shares of GKOS stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,972

Previous 29,871 9.71%

Holding current value

$2.27 Million

Previous $2.94 Million 5.24%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$82.27 - $103.29 $238,500 - $299,437	-2,899 Reduced 9.71%	26,972 $2.79 Million
Q1 2025 May 08, 2025	SELL	$96.6 - $161.22 $427,744 - $713,882	-4,428 Reduced 12.91%	29,871 $2.94 Million
Q4 2024 Feb 10, 2025	SELL	$126.42 - $152.67 $434,758 - $525,032	-3,439 Reduced 9.11%	34,299 $5.14 Million
Q3 2024 Nov 06, 2024	BUY	$113.62 - $135.39 $50,106 - $59,706	441 Added 1.18%	37,738 $4.92 Million
Q2 2024 Aug 01, 2024	BUY	$89.48 - $118.35 $372,057 - $492,099	4,158 Added 12.55%	37,297 $4.41 Million
Q1 2024 Apr 25, 2024	SELL	$76.4 - $96.33 $441,668 - $556,883	-5,781 Reduced 14.85%	33,139 $3.13 Million
Q4 2023 Feb 06, 2024	BUY	$59.53 - $85.11 $294,137 - $420,528	4,941 Added 14.54%	38,920 $3.09 Million
Q3 2023 Nov 13, 2023	BUY	$69.23 - $79.09 $89,860 - $102,658	1,298 Added 3.97%	33,979 $2.56 Million
Q2 2023 Aug 15, 2023	BUY	$45.44 - $71.21 $669,240 - $1.05 Million	14,728 Added 82.04%	32,681 $2.33 Million
Q1 2023 May 11, 2023	BUY	$43.88 - $52.48 $326,818 - $390,871	7,448 Added 70.9%	17,953 $899,000
Q4 2022 Jan 27, 2023	SELL	$40.82 - $57.75 $346,357 - $490,008	-8,485 Reduced 44.68%	10,505 $459,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $376,499 - $470,142	8,038 Added 73.39%	18,990 $1.01 Million
Q2 2022 Aug 12, 2022	SELL	$34.86 - $63.77 $24,402 - $44,639	-700 Reduced 6.01%	10,952 $497,000
Q1 2022 May 12, 2022	BUY	$44.33 - $57.82 $516,533 - $673,718	11,652 New	11,652 $674,000

Others Institutions Holding GKOS

# of Institutions

334

Shares Held

54.2M

Call Options Held

259K

Put Options Held

481K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Glaukos Corp Transaction History